Clinical mass spectrometry-achieving prominence in laboratory medicine

Clinical Chemistry

Volumn 62, Issue 1, 2016, Pages 1-3

  Annesley, Thomas M ^a   Graham Cooks, R ^b   Herold, David A ^c   Hoofnagle, Andrew N ^d  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOGENIC AMINE; CARBOXYLIC ACID; HEMOGLOBIN A1C; INSULIN; LIPID; RIBOSOME RNA; STEROID; TROPONIN; VITAMIN D;

ARTICLE; AUTOANALYZER; CLINICAL LABORATORY; COLORIMETRY; ELECTROSPRAY; FOOD AND DRUG ADMINISTRATION; GENETIC DISORDER; HUMAN; IMMUNOASSAY; LABORATORY TEST; MASS SPECTROMETRY; NEWBORN SCREENING; PHARMACOGENETICS; SPECTROPHOTOMETER; WEB OF SCIENCE; CLINICAL MEDICINE; DEVICES; LABORATORY;

CLINICAL LABORATORY TECHNIQUES; CLINICAL MEDICINE; HUMANS; LABORATORIES; MASS SPECTROMETRY;

EID: 84954561702     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.251272     Document Type: Article

References (20)

1. Jannetto PJ, Fitzgerald RL. Effective use of mass spectrometry in the clinical laboratory. Clin Chem 2016;62:92-8.
2. McMullen AR, Burnham C. Be serious: posttraumatic endophthalmitis. Clin Chem 2016;62:37-8.
3. Ifa DR, Eberlin LS. Ambient ionization mass spectrometry for cancer diagnosis and surgical margin evaluation. Clin Chem 2016;62:111-23.
4. Clarke NJ. Mass spectrometry in precision medicine: phenotypic measurements alongside pharmacogenomics. Clin Chem 2016;62:70-6.
5. Ketha H, Kumar R, Singh RJ. LC-MS/MS for identifying patients with CYP24A1 mutations. Clin Chem 2016;62:236-41.
6. Zhang W, James PM, Ng BG, Li X, Xia B, Rong J, et al. A novel N-tetrasaccharide in patients with congenital disorders of glycosylation, including asparagine-linked glycosylation protein 1, phosphomannomutase 2, and mannose phosphate isomerase deficiencies. Clin Chem 2016;62:208-17.
7. Bergen HR III, Dasari S, Dispenzieri A, Mills JR, Ramirez-Alvarado M, Tschumper RC, et al. Clonotypic light chain peptides identified for monitoring minimal residual disease in multiple myeloma without bone marrow aspiration. Clin Chem 2016;62:243-51.
8. Kushnir MM, Rockwood AL, Strathmann FG, Frank EL, Straseski JA, Meikle AW. LC-MS/MS measurement of parathyroid hormone-related peptide. Clin Chem 2016;62:218-26.
9. Lee AYH, Chappell DL, Bak MJ, Judo M, Liang L, Churakova T, et al. Multiplexed quantification of proglucagonderived peptides by immunoaffinity enrichment and tandem mass spectrometry after a meal tolerance test. Clin Chem 2016;62:227-35.
10. Henderson CM, Lutsey PL, Misialek JR, Laha TJ, Selvin E, Eckfeldt JH, Hoofnagle AN. Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D-binding protein in blacks and whites. Clin Chem 2016;62:179-87.
11. Hawley JM, Owen LJ, MacKenzie F, Mussell C, Cowen S, Keevil BG. Candidate reference measurement procedure for the quantification of total serum cortisol with LC-MS/MS. Clin Chem 2016;62:262-9.
12. Diao X, Wohlfarth A, Pang S, Scheidweiler KB, Huestis MA. High-resolution mass spectrometry for characterizing the metabolism of synthetic cannabinoid THJ-018 and its 5-fluoro analog THJ-2201 after incubation in human hepatocytes. Clin Chem 2016;62:157-69.
13. Thoren KL, Colby JM, Shugarts SB, Wu AHB, Lynch KL. Comparison of information-dependent acquisition on a tandem quadrupole TOF vs a triple quadrupole linear ion trap mass spectrometer for broad-spectrum drug screening. Clin Chem 2016;62:170-8.
14. Landau M. An interview with David Millington. Clin Chem 2016;62:12-9.
15. Lathrop JT, Jeffery DA, Shea YR, Scholl PF, Chan MM. US Food and Drug Administration perspectives on clinical mass spectrometry. Clin Chem 2016;62:41-7.
16. Hoofnagle AN, Whiteaker JR, Carr SA, Kuhn E, Liu T, Massoni SA, et al. Recommendationsfor the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays. Clin Chem 2016;62:48-69.
17. Lynch K. CLSI C62-A: A new standard for clinical mass spectrometry. Clin Chem 2016;62:24-9.
18. Rappold BA. Mass spectrometry selectivity, specifically. Clin Chem 2016;62:154-6.
19. Annesley TM, Diamandis EP, Bachmann LM, Hanash S, Hart B, Javahery R, et al. A spectrum of views on clinical mass spectrometry. Clin Chem 2016;62:30-6.
20. Ferreira CR, Yannell KE, Jarmusch AK, Pirro V, Ouyang Z, Cooks RG. Ambient ionization mass spectrometry for point-of-care diagnostics and other clinical measurements. Clin Chem 2016;62:99-110.